BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35130803)

  • 1. WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
    Vaz A; Roldão Santos M; Gwaza L; Mezquita González E; Pajewska Lewandowska M; Azatyan S; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2022 Jan; 15(1):11-17. PubMed ID: 35130803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliance: a smarter way of regulating medical products - The IPRP survey.
    Doerr P; Valentin M; Nakashima N; Orphanos N; Santos G; Balkamos G; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2021 Feb; 14(2):173-177. PubMed ID: 33355025
    [No Abstract]   [Full Text] [Related]  

  • 3. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
    Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
    Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.
    McAuslane N; Bujar M; Sithole T; Ngum N; Owusu-Asante M; Walker S
    Pharmaceut Med; 2023 May; 37(3):251-260. PubMed ID: 37074548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliance is key to effective access and oversight of medical products in case of public health emergencies.
    Saint-Raymond A; Valentin M; Nakashima N; Orphanos N; Santos G; Balkamos G; Azatyan S
    Expert Rev Clin Pharmacol; 2022 Jul; 15(7):805-810. PubMed ID: 35945703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European Medicines Agency facilitates access to medicines in low- and middle-income countries.
    Cavaller Bellaubi M; Harvey Allchurch M; Lagalice C; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):321-325. PubMed ID: 32053756
    [No Abstract]   [Full Text] [Related]  

  • 8. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
    Roth L; Bempong D; Babigumira JB; Banoo S; Cooke E; Jeffreys D; Kasonde L; Leufkens HGM; Lim JCW; Lumpkin M; Mahlangu G; Peeling RW; Rees H; Ndomondo-Sigonda M; Stergachis A; Ward M; Nwokike J
    Global Health; 2018 Nov; 14(1):102. PubMed ID: 30382856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities.
    Danks L; Semete-Makokotlela B; Otwombe K; Parag Y; Walker S; Salek S
    Front Med (Lausanne); 2023; 10():1265058. PubMed ID: 37937144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide Regulatory Reliance: Launching A Pilot on A Chemistry, Manufacturing and Control Post Approval Change for A Vaccine.
    Gastineau T; Ban C; Basso A; Brehme F; Silva AL; Faure O; Le Palaire L; Persaud P; Rodriguez H
    PDA J Pharm Sci Technol; 2023 Nov; ():. PubMed ID: 37973190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?
    Doua JY; Van Geertruyden JP
    Trop Med Int Health; 2014 Jan; 19(1):23-36. PubMed ID: 24134396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries.
    Shabangu PP; Kuwana RJ; Dube A
    Front Med (Lausanne); 2022; 9():975032. PubMed ID: 36160156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registration pathways to accelerate regulatory assessment of innovative medicines in Latin America.
    Padua A; Partika L; Bonamici D; Rahal Cabello J; Kohiyama C; Spinardi P; Castro A; Rolim A; Souto F
    J Public Health Policy; 2020 Dec; 41(4):481-495. PubMed ID: 32879437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries.
    Durán CE; Cañás M; Urtasun MA; Elseviers M; Andia T; Vander Stichele R; Christiaens T
    Rev Panam Salud Publica; 2021; 45():e10. PubMed ID: 33859678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
    Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
    Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries.
    Dellepiane N; Akanmori BD; Gairola S; Jadhav SS; Parker C; Rodriguez C; Srivastava S
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S428-33. PubMed ID: 26553671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
    Sithole T; Mahlangu G; Walker S; Salek S
    Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
    Ncube BM; Dube A; Ward K
    Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WHO Global Benchmarking Tool: a game changer for strengthening national regulatory capacity.
    Guzman J; O'Connell E; Kikule K; Hafner T
    BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32784212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.